NCT05294640

Brief Summary

The investigators aim to assess whether bacteriostatic saline provides the same level of anesthesia as traditional local anesthesia while reducing pain associated with medication infusion in minor eyelid procedures

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started May 2022

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 8, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

March 24, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

May 17, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 21, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 21, 2023

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

June 25, 2025

Completed
Last Updated

July 8, 2025

Status Verified

June 1, 2025

Enrollment Period

9 months

First QC Date

March 8, 2022

Results QC Date

February 20, 2024

Last Update Submit

July 3, 2025

Conditions

Keywords

OculoplasticsLocal AnesthesiaEyelid AnesthesiaPeriocular Anesthesia

Outcome Measures

Primary Outcomes (2)

  • Pain on Injection

    Pain on a scale of 0-10 during injection process (0 being no pain, 10 being worst pain ever experienced). These will be patient-reported verbally and recorded immediately after injection.

    5 minutes

  • Pain of Procedure

    Pain on a scale of 0-10 during procedure (0 being no pain, 10 being worst pain ever experienced). These will be patient-reported verbally and recorded immediately after procedure.

    10 minutes

Secondary Outcomes (2)

  • Number of Lesions That Needed Additional Anesthesia to Complete Procedure

    10 minutes

  • Bleeding Level

    10 minutes

Study Arms (2)

Bacteriostatic Saline as Local Anesthesia

EXPERIMENTAL

Patients receiving bacteriostatic saline as local anesthesia for in-office minor eyelid procedures at University of California, San Francisco Medical Center, Oculoplastics department

Drug: 0.9% Bacteriostatic Local Anesthetic InjectionProcedure: Eyelid Lesion Removal

Lidocaine with Epinephrine as Local Anesthesia

ACTIVE COMPARATOR

Patients receiving lidocaine with epinephrine as local anesthesia for in-office minor eyelid procedures at University of California, San Francisco Medical Center, Oculoplastics department

Drug: 1% Lidocaine with 1:100,000 epinephrine Local Anesthetic InjectionProcedure: Eyelid Lesion Removal

Interventions

Following research and procedural consent, local anesthetic injection will be carried out using a standard 1 cc of local anesthetic corresponding to the study arm (0.9% bacteriostatic saline or 1% lidocaine with 1:100,000 epinephrine). Prior to anesthetic administration, the procedure site will be cleaned using standard measures. A 30 gauge needle on a 3 centimeter cubed volume syringe will be utilized. Five minutes will be given for local anesthetic to take effect.

Bacteriostatic Saline as Local Anesthesia

Following research and procedural consent, local anesthetic injection will be carried out using a standard 1 cc of local anesthetic consisting of a commercially available mixture of 1% lidocaine with 1:100,000 epinephrine. Prior to anesthetic administration, the procedure site will be cleaned using standard measures. A 30 gauge needle on a 3 centimeter cubed volume syringe will be utilized. Five minutes will be given for local anesthetic to take effect.

Lidocaine with Epinephrine as Local Anesthesia

Following anesthesia administration, patient will proceed with recommended eyelid lesion removal. The procedure site will be cleaned according to standard protocol, and standard technique for lesion removal will be performed, which will vary according to type of lesion but may involve use of Westcott scissors, forceps, #15 or #11 blades or other oculoplastics administration. The exact procedural details will be at the discretion of the surgeon.

Bacteriostatic Saline as Local AnesthesiaLidocaine with Epinephrine as Local Anesthesia

Eligibility Criteria

Age18 Years - 110 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>=18 years old
  • Undergoing clinic-based periocular procedure

You may not qualify if:

  • Any other topical, oral or intravenous sedating medications given alongside procedure
  • Allergy to saline, lidocaine or epinephrine
  • Unable to provide consent due to cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California at San Francisco

San Francisco, California, 94158, United States

Location

Related Publications (10)

  • Wilson L, Martin S. Benzyl alcohol as an alternative local anesthetic. Ann Emerg Med. 1999 May;33(5):495-9. doi: 10.1016/s0196-0644(99)70335-5.

    PMID: 10216324BACKGROUND
  • Minogue SC, Sun DA. Bacteriostatic saline containing benzyl alcohol decreases the pain associated with the injection of propofol. Anesth Analg. 2005 Mar;100(3):683-686. doi: 10.1213/01.ANE.0000148617.98716.EB.

    PMID: 15728052BACKGROUND
  • Patterson P, Hussa AA, Fedele KA, Vegh GL, Hackman CM. Comparison of 4 analgesic agents for venipuncture. AANA J. 2000 Feb;68(1):43-51.

    PMID: 10876451BACKGROUND
  • Miller L, Jensen MP, Stenchever MA. A double-blind randomized comparison of lidocaine and saline for cervical anesthesia. Obstet Gynecol. 1996 Apr;87(4):600-4. doi: 10.1016/0029-7844(95)00463-7.

    PMID: 8602315BACKGROUND
  • Kruse RC, Kindle BJ, Wisniewski S, Presley J, Smith J, Sellon JL. Local Anesthesia Prior to Ultrasound-Guided Hip Joint Injections: A Double-Blind Randomized Controlled Trial of Bacteriostatic Saline versus Buffered Lidocaine. PM R. 2021 Aug;13(8):811-818. doi: 10.1002/pmrj.12489. Epub 2020 Nov 23.

    PMID: 32935453BACKGROUND
  • Kwiat DM, Bersani TA, Bersani A. Increased patient comfort utilizing botulinum toxin type a reconstituted with preserved versus nonpreserved saline. Ophthalmic Plast Reconstr Surg. 2004 May;20(3):186-9. doi: 10.1097/01.iop.0000129012.09632.49.

    PMID: 15167724BACKGROUND
  • Hunt SV, Malhotra R. Bacteriostatic preserved saline for pain-free periocular injections: review. Eye (Lond). 2022 Aug;36(8):1546-1552. doi: 10.1038/s41433-021-01925-z. Epub 2022 Jan 11.

    PMID: 35017698BACKGROUND
  • Yuen VH, Dolman PJ. Comparison of three modified lidocaine solutions for use in eyelid anesthesia. Ophthalmic Plast Reconstr Surg. 1999 Mar;15(2):143-7. doi: 10.1097/00002341-199903000-00017.

    PMID: 10189646BACKGROUND
  • Lugo-Janer G, Padial M, Sanchez JL. Less painful alternatives for local anesthesia. J Dermatol Surg Oncol. 1993 Mar;19(3):237-40. doi: 10.1111/j.1524-4725.1993.tb00342.x.

    PMID: 8383150BACKGROUND
  • Oman KS, Fink R, Kleiner C, Makic MB, Wenger B, Hoffecker L, Mancuso M, Schmiege S, Cook P. Intradermal lidocaine or bacteriostatic normal saline to decrease pain before intravenous catheter insertion: a meta-analysis. J Perianesth Nurs. 2014 Oct;29(5):367-76. doi: 10.1016/j.jopan.2013.12.008.

    PMID: 25261140BACKGROUND

MeSH Terms

Conditions

Eyelid NeoplasmsHordeolum

Interventions

Lidocaine

Condition Hierarchy (Ancestors)

Facial NeoplasmsHead and Neck NeoplasmsNeoplasms by SiteNeoplasmsEye NeoplasmsEye DiseasesEyelid DiseasesEye Infections, BacterialBacterial InfectionsBacterial Infections and MycosesInfectionsEye Infections

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Results Point of Contact

Title
Meleha Ahmad
Organization
Moyes Eye Center

Study Officials

  • Robert Kersten, MD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Patient and provider performing procedure will be masked to local anesthesia type
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 8, 2022

First Posted

March 24, 2022

Study Start

May 17, 2022

Primary Completion

February 21, 2023

Study Completion

February 21, 2023

Last Updated

July 8, 2025

Results First Posted

June 25, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations